17/09/2025 08:00
R.E.A. Holdings plc: Half yearly results
INFORMATION REGLEMENTEE

R.E.A. Holdings plc (RE.)
R.E.A. Holdings plc: Half yearly results

17-Sep-2025 / 07:00 GMT/BST



R.E.A. Holdings plc (“REA” or the “company”)


 


REA today publishes the group’s half yearly report for the six months to 30 June 2025. Please click on the link below to view.


 


The 2025 half yearly report will also be available shortly at www.rea.co.uk/investors/financial-reports.


 


HIGHLIGHTS


 


Strategic


 


  • Maturity profile of group debt improved
  • Sale of outlying subsidiary CDM completed in June 2025

 


Financial


 


  • Revenue increased by 14 per cent to $92.4 million (2024: $80.9 million) benefitting from continuing firm prices for both CPO and CPKO
  • Average selling prices (including premia for certified oil but net of export duty and levy) for CPO some 13 per cent above 2024 at $856 per tonne (2024: $755 per tonne) and for CPKO some 96 per cent above 2024 at $1,657 per tonne (2024: $847 per tonne)
  • EBITDA for the period of $33.4 million (2024: $21.6 million), a 55 per cent increase
  • Profit before tax of $11.6 million (2024: $8.1 million) before $5.7 million loss on disposal of CDM notwithstanding $8.9 million adverse swing in exchange movements
  • Group net indebtedness at $159.1 million (31 December 2024: $159.3 million) after temporary increase in working capital of $15.0 million
  • Indonesian bank loans repackaged in March 2025
  • £21.4 million nominal of sterling notes redeemed at 104 per cent on 31 August 2025
  • In September 2025, repayment date of at least $17.6 million nominal of dollar notes postponed to 31 December 2028

 


Agricultural operations


 


  • FFB production for the continuing group (excluding CDM) of 425,061 tonnes (2024: 399,907 tonnes) despite reduced hectarage due to the replanting programme and exceptionally heavy rainfall in the early months
  • Extraction rates maintained above 22 per cent
  • Replanting and extension planting on target

 


Stone and sand operations


 


  • Production and sales of ATP stone now accelerating
  • ATP sale contracts signed with three substantial purchasers of stone
  • Sand washing plant being enhanced with scale production projected in 2026
  • Both ATP and MCU now under direct control of the group

 


Sustainability and climate


 


  • 100 per cent of the group’s own plantations are now RSPO certified
  • Projects to promote sustainable development and climate action, including smallholders, continuing apace

 


Outlook


 


  • Firm CPO prices projected for the immediate future
  • Group FFB production expected to increase from 2026 as immature areas start to substitute for mature areas taken out of production for replanting with additional FFB expected from Enggang areas now managed by the group
  • Cash flows to progressively reap the benefits of capital investments in replanting, new planting and scaling up of the stone and sand operations
  • Group’s financial position continuing to strengthen with an increasingly encouraging outlook

 


 


CONSOLIDATED INCOME STATEMENT


FOR THE SIX MONTHS ENDED 30 JUNE 2025


 


 


30 June


30 June


31 December


 


2025


2024


2024


 


$’000


$’000


$’000


Revenue


92,410


80,945


187,943


Net gain / (loss) arising from changes in fair value of biological assets


478


(169)


9


Cost of sales


(63,012)


(63,580)


(136,495)


Gross profit


29,876


17,196


51,457


Distribution costs


(507)


(576)


(1,281)


Administrative expenses


(10,151)


(7,993)


(15,208)


Operating profit


19,218


8,627


34,968


Interest income


701


1,167


3,369


Reversal of provision




6,622


(Losses) / gains on disposal of subsidiaries and similar charges


(5,723)



3,051


Other (losses) / gains


(2,428)


6,499


7,317


Finance costs


(5,911)


(8,233)


(16,430)


Profit before tax


5,857


8,060


38,897


Tax


(8,444)


(4,520)


(8,434)


(Loss) / profit for the period


(2,587)


3,540


30,463


 


 


 


 


Attributable to:


 


 


 


Equity shareholders


(2,425)


1,530


26,447


Non-controlling interests


(162)


2,010


4,016


 


(2,587)


3,540


30,463


 


 


 


 


(Loss) / profit per 25p ordinary share (US cents)


 


 


 


Basic


(15.6)


(5.9)


41.6


Diluted


(15.6)


(5.9)


41.6


 


All operations in all periods are continuing.


 


 


CONSOLIDATED BALANCE SHEET


AS AT 30 JUNE 2025


 


 


30 June


30 June


31 December


 


2025


2024


2024


 


$’000


$’000


$’000


Non-current assets


 


 


 


Goodwill


11,144


11,144


11,144


Intangible assets


2,331


1,401


2,684


Property, plant and equipment


372,280


310,198


386,997


Land


54,295


51,166


58,098


Financial assets


24,902


77,578


26,735


Deferred tax assets


16,364


14,126


21,278


Total non-current assets


481,316


465,613


506,936


Current assets


 


 


 


Inventories


25,403


20,956


18,393


Biological assets


3,816


3,160


3,338


Trade and other receivables


39,996


34,885


31,312


Current tax asset


1,243


1,058


228


Cash and cash equivalents


55,208


15,942


38,837


Total current assets


125,666


76,001


92,108


Total assets


606,982


541,614


599,044


Current liabilities


 


 


 


Trade and other payables


(33,552)


(30,032)


(44,715)


Bank loans


(24,068)


(23,145)


(20,012)


Sterling notes


(30,429)



(28,167)


Dollar notes


(26,829)




Other loans and payables


(8,649)


(6,928)


(2,707)


Total current liabilities


(123,527)


(60,105)


(95,601)


Non-current liabilities


 


 


 


Trade and other payables



(4,252)



Bank loans


(132,944)


(81,330)


(114,417)


Sterling notes



(40,316)



Dollar notes



(26,658)


(26,746)


Deferred tax liabilities


(50,923)


(34,654)


(47,404)


Other loans and payables


(11,129)


(21,373)


(19,897)


Total non-current liabilities


(194,996)


(208,583)


(208,464)


Total liabilities


(318,523)


(268,688)


(304,065)


Net assets


288,459


272,926


294,979


 


 


 


 


Equity


 


 


 


Share capital


133,590


133,590


133,590


Share premium account


47,374


47,374


47,374


Translation reserve


(25,824)


(24,416)


(26,332)


Retained earnings


62,960


47,836


69,826


 


218,100


204,384


224,458


Non-controlling interests


70,359


68,542


70,521


Total equity


288,459


272,926


294,979


 


 


CONSOLIDATED CASH FLOW STATEMENT


FOR THE SIX MONTHS ENDED 30 JUNE 2025


 


 


30 June


30 June


31 December


 


2025


2024


2024


 


$’000


$’000


$’000


Net cash from / (used in) operating activities


5,770


(4,712)


31,751


 


 


 


 


Investing activities


 


 


 


Interest received


701


1,167


1,069


Proceeds on disposal of PPE



13


4,179


Purchases of intangible assets and PPE


(16,040)


(9,773)


(34,621)


Expenditure on land


(664)


(684)


(4,530)


Net investment stone and coal interests



(4,227)


(3,610)


Net investment sand interest


(3,070)



(4,413)


Cash received from non-current receivables



1,298


1,258


Cash acquired with new subsidiary




259


Cash divested on disposal of group company


(372)




Cash reclassified from asset held for sale



9


9


Net proceeds on disposal of group company


8,365




Net cash used in investing activities


(11,080)


(12,197)


(40,400)


 


 


 


 


Financing activities


 


 


 


Preference dividends paid


(4,414)


(14,510)


(18,576)


Repayment of bank borrowings


(9,804)


(7,540)


(36,862)


New bank borrowings drawn


47,570


6,494


64,342


Purchase of sterling notes for cancellation


(381)



(11,606)


Repayment of borrowings from non-controlling shareholder


(8,750)


(11,747)


(12,234)


New equity from non-controlling interests



50,000


53,580


Cost of non-controlling interest transaction



(1,078)


(1,078)


Purchase of non-controlling interest



(2,726)


(2,726)


Repayment of lease liabilities


(1,500)


(1,271)


(2,724)


Net cash from financing activities


22,721


17,622


32,116


 


 


 


 


Cash and cash equivalents


 


 


 


Net increase in cash and cash equivalents


17,411


713


23,467


Cash and cash equivalents at beginning of period


38,837


14,195


14,195


Effect of exchange rate changes


(1,040)


1,034


1,175


Cash and cash equivalents at end of period


55,208


15,942


38,837


 


 


 


 


Enquiries:


R.E.A Holdings plc


Tel: +44 (0)20 7436 7877



Attachment

File: REA Half yearly report 2025


Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


ISIN: GB0002349065
Category Code: IR
TIDM: RE.
LEI Code: 213800YXL94R94RYG150
Sequence No.: 401996
EQS News ID: 2198392

 
End of Announcement EQS News Service



















R.E.A. Holdings plc (RE.)







R.E.A. Holdings plc: Half yearly results

17-Sep-2025 / 07:00 GMT/BST




R.E.A. Holdings plc (“REA” or the “company”)



 



REA today publishes the group’s half yearly report for the six months to 30 June 2025. Please click on the link below to view.



 



The 2025 half yearly report will also be available shortly at www.rea.co.uk/investors/financial-reports.



 



HIGHLIGHTS



 



Strategic



 



  • Maturity profile of group debt improved

  • Sale of outlying subsidiary CDM completed in June 2025

 



Financial



 



  • Revenue increased by 14 per cent to $92.4 million (2024: $80.9 million) benefitting from continuing firm prices for both CPO and CPKO

  • Average selling prices (including premia for certified oil but net of export duty and levy) for CPO some 13 per cent above 2024 at $856 per tonne (2024: $755 per tonne) and for CPKO some 96 per cent above 2024 at $1,657 per tonne (2024: $847 per tonne)

  • EBITDA for the period of $33.4 million (2024: $21.6 million), a 55 per cent increase

  • Profit before tax of $11.6 million (2024: $8.1 million) before $5.7 million loss on disposal of CDM notwithstanding $8.9 million adverse swing in exchange movements

  • Group net indebtedness at $159.1 million (31 December 2024: $159.3 million) after temporary increase in working capital of $15.0 million

  • Indonesian bank loans repackaged in March 2025

  • £21.4 million nominal of sterling notes redeemed at 104 per cent on 31 August 2025

  • In September 2025, repayment date of at least $17.6 million nominal of dollar notes postponed to 31 December 2028

 



Agricultural operations



 



  • FFB production for the continuing group (excluding CDM) of 425,061 tonnes (2024: 399,907 tonnes) despite reduced hectarage due to the replanting programme and exceptionally heavy rainfall in the early months

  • Extraction rates maintained above 22 per cent

  • Replanting and extension planting on target

 



Stone and sand operations



 



  • Production and sales of ATP stone now accelerating

  • ATP sale contracts signed with three substantial purchasers of stone

  • Sand washing plant being enhanced with scale production projected in 2026

  • Both ATP and MCU now under direct control of the group

 



Sustainability and climate



 



  • 100 per cent of the group’s own plantations are now RSPO certified

  • Projects to promote sustainable development and climate action, including smallholders, continuing apace

 



Outlook



 



  • Firm CPO prices projected for the immediate future

  • Group FFB production expected to increase from 2026 as immature areas start to substitute for mature areas taken out of production for replanting with additional FFB expected from Enggang areas now managed by the group

  • Cash flows to progressively reap the benefits of capital investments in replanting, new planting and scaling up of the stone and sand operations

  • Group’s financial position continuing to strengthen with an increasingly encouraging outlook

 



 



CONSOLIDATED INCOME STATEMENT



FOR THE SIX MONTHS ENDED 30 JUNE 2025



 
















































































































 



30 June



30 June



31 December



 



2025



2024



2024



 



$’000



$’000



$’000



Revenue



92,410



80,945



187,943



Net gain / (loss) arising from changes in fair value of biological assets



478



(169)



9



Cost of sales



(63,012)



(63,580)



(136,495)



Gross profit



29,876



17,196



51,457



Distribution costs



(507)



(576)



(1,281)



Administrative expenses



(10,151)



(7,993)



(15,208)



Operating profit



19,218



8,627



34,968



Interest income



701



1,167



3,369



Reversal of provision







6,622



(Losses) / gains on disposal of subsidiaries and similar charges



(5,723)





3,051



Other (losses) / gains



(2,428)



6,499



7,317



Finance costs



(5,911)



(8,233)



(16,430)



Profit before tax



5,857



8,060



38,897



Tax



(8,444)



(4,520)



(8,434)



(Loss) / profit for the period



(2,587)



3,540



30,463



 



 



 



 



Attributable to:



 



 



 



Equity shareholders



(2,425)



1,530



26,447



Non-controlling interests



(162)



2,010



4,016



 



(2,587)



3,540



30,463



 



 



 



 



(Loss) / profit per 25p ordinary share (US cents)



 



 



 



Basic



(15.6)



(5.9)



41.6



Diluted



(15.6)



(5.9)



41.6


 



All operations in all periods are continuing.



 



 



CONSOLIDATED BALANCE SHEET



AS AT 30 JUNE 2025



 
























































































































































































 



30 June



30 June



31 December



 



2025



2024



2024



 



$’000



$’000



$’000



Non-current assets



 



 



 



Goodwill



11,144



11,144



11,144



Intangible assets



2,331



1,401



2,684



Property, plant and equipment



372,280



310,198



386,997



Land



54,295



51,166



58,098



Financial assets



24,902



77,578



26,735



Deferred tax assets



16,364



14,126



21,278



Total non-current assets



481,316



465,613



506,936



Current assets



 



 



 



Inventories



25,403



20,956



18,393



Biological assets



3,816



3,160



3,338



Trade and other receivables



39,996



34,885



31,312



Current tax asset



1,243



1,058



228



Cash and cash equivalents



55,208



15,942



38,837



Total current assets



125,666



76,001



92,108



Total assets



606,982



541,614



599,044



Current liabilities



 



 



 



Trade and other payables



(33,552)



(30,032)



(44,715)



Bank loans



(24,068)



(23,145)



(20,012)



Sterling notes



(30,429)





(28,167)



Dollar notes



(26,829)







Other loans and payables



(8,649)



(6,928)



(2,707)



Total current liabilities



(123,527)



(60,105)



(95,601)



Non-current liabilities



 



 



 



Trade and other payables





(4,252)





Bank loans



(132,944)



(81,330)



(114,417)



Sterling notes





(40,316)





Dollar notes





(26,658)



(26,746)



Deferred tax liabilities



(50,923)



(34,654)



(47,404)



Other loans and payables



(11,129)



(21,373)



(19,897)



Total non-current liabilities



(194,996)



(208,583)



(208,464)



Total liabilities



(318,523)



(268,688)



(304,065)



Net assets



288,459



272,926



294,979



 



 



 



 



Equity



 



 



 



Share capital



133,590



133,590



133,590



Share premium account



47,374



47,374



47,374



Translation reserve



(25,824)



(24,416)



(26,332)



Retained earnings



62,960



47,836



69,826



 



218,100



204,384



224,458



Non-controlling interests



70,359



68,542



70,521



Total equity



288,459



272,926



294,979


 



 



CONSOLIDATED CASH FLOW STATEMENT



FOR THE SIX MONTHS ENDED 30 JUNE 2025



 




















































































































































 



30 June



30 June



31 December



 



2025



2024



2024



 



$’000



$’000



$’000



Net cash from / (used in) operating activities



5,770



(4,712)



31,751



 



 



 



 



Investing activities



 



 



 



Interest received



701



1,167



1,069



Proceeds on disposal of PPE





13



4,179



Purchases of intangible assets and PPE



(16,040)



(9,773)



(34,621)



Expenditure on land



(664)



(684)



(4,530)



Net investment stone and coal interests





(4,227)



(3,610)



Net investment sand interest



(3,070)





(4,413)



Cash received from non-current receivables





1,298



1,258



Cash acquired with new subsidiary







259



Cash divested on disposal of group company



(372)







Cash reclassified from asset held for sale





9



9



Net proceeds on disposal of group company



8,365







Net cash used in investing activities



(11,080)



(12,197)



(40,400)



 



 



 



 



Financing activities



 



 



 



Preference dividends paid



(4,414)



(14,510)



(18,576)



Repayment of bank borrowings



(9,804)



(7,540)



(36,862)



New bank borrowings drawn



47,570



6,494



64,342



Purchase of sterling notes for cancellation



(381)





(11,606)



Repayment of borrowings from non-controlling shareholder



(8,750)



(11,747)



(12,234)



New equity from non-controlling interests





50,000



53,580



Cost of non-controlling interest transaction





(1,078)



(1,078)



Purchase of non-controlling interest





(2,726)



(2,726)



Repayment of lease liabilities



(1,500)



(1,271)



(2,724)



Net cash from financing activities



22,721



17,622



32,116



 



 



 



 



Cash and cash equivalents



 



 



 



Net increase in cash and cash equivalents



17,411



713



23,467



Cash and cash equivalents at beginning of period



38,837



14,195



14,195



Effect of exchange rate changes



(1,040)



1,034



1,175



Cash and cash equivalents at end of period



55,208



15,942



38,837


 



 



 



 



Enquiries:



R.E.A Holdings plc



Tel: +44 (0)20 7436 7877





Attachment

File: REA Half yearly report 2025



Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.




The issuer is solely responsible for the content of this announcement.
















ISIN: GB0002349065
Category Code: IR
TIDM: RE.
LEI Code: 213800YXL94R94RYG150
Sequence No.: 401996
EQS News ID: 2198392





 
End of Announcement EQS News Service








\"\"